Cardiol Therapeutics Inc Class A

Yahoo Finance • 13 days ago

Cardiol Therapeutics Announces Year-End 2025 Update on Operations

Initiated pivotal Phase III MAVERIC trial of CardiolRx™ in recurrent pericarditis and surpassed 50% patient enrollment, with full enrollment expected in Q2 2026. Reported positive Phase II ARCHER data showing CardiolRx™ significantly reduc... Full story

Yahoo Finance • 6 months ago

ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City

NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan... Full story

Yahoo Finance • 9 months ago

Cardiol rises on database lockup for acute myocarditis therapy trial

[Stethoscope] adventtr/E+ via Getty Images * Cardiol Therapeutics (NASDAQ:CRDL [https://seekingalpha.com/symbol/CRDL]) shares up after it announced database lock for a mid-stage trial testing its lead asset, CardiolRx, on myocardial rec... Full story

Yahoo Finance • 9 months ago

Cardiol Therapeutics announces database lock for myocarditis trial

TORONTO - Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL), a clinical-stage biotechnology company with a current market capitalization of $100.83 million, announced Tuesday the database lock for its Phase II ARCHER trial investigating C... Full story

Yahoo Finance • 4 years ago

Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 P.M. EDT

Oakville, Ontario--(Newsfile Corp. - June 27, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of cannabidiol... Full story

Yahoo Finance • 4 years ago

CEO Presenting on the Emerging Growth Conference on May 25 Register Now

MIAMI, May 24, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of t... Full story